Antimutagenic compounds and their possible mechanisms of action

2014
journal article
review article
173
dc.abstract.enMutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described.pl
dc.affiliationWydział Farmaceutyczny : Zakład Biochemii Farmaceutycznejpl
dc.affiliationWydział Farmaceutyczny : Zakład Chemii Bioorganicznejpl
dc.cm.date2020-01-07
dc.cm.id64823
dc.contributor.authorSłoczyńska, Karolina - 200093 pl
dc.contributor.authorPowroźnik, Beata - 139508 pl
dc.contributor.authorPękala, Elżbieta - 133125 pl
dc.contributor.authorWaszkielewicz, Anna - 242824 pl
dc.date.accessioned2020-01-17T08:42:36Z
dc.date.available2020-01-17T08:42:36Z
dc.date.issued2014pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number2pl
dc.description.physical273-285pl
dc.description.points20pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume55pl
dc.identifier.doi10.1007/s13353-014-0198-9pl
dc.identifier.eissn2190-3883pl
dc.identifier.issn1234-1983pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/133324
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa*
dc.rights.licenceCC-BY
dc.rights.urihttps://creativecommons.org/licenses*
dc.share.typeinne
dc.source.integratorfalse
dc.subject.enantimutagenpl
dc.subject.enantimutagenicitypl
dc.subject.enDNA damagepl
dc.subject.enmutagenpl
dc.subject.enmutagenicitypl
dc.subtypeReviewArticlepl
dc.titleAntimutagenic compounds and their possible mechanisms of actionpl
dc.title.journalJournal of Applied Geneticspl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described.
dc.affiliationpl
Wydział Farmaceutyczny : Zakład Biochemii Farmaceutycznej
dc.affiliationpl
Wydział Farmaceutyczny : Zakład Chemii Bioorganicznej
dc.cm.date
2020-01-07
dc.cm.id
64823
dc.contributor.authorpl
Słoczyńska, Karolina - 200093
dc.contributor.authorpl
Powroźnik, Beata - 139508
dc.contributor.authorpl
Pękala, Elżbieta - 133125
dc.contributor.authorpl
Waszkielewicz, Anna - 242824
dc.date.accessioned
2020-01-17T08:42:36Z
dc.date.available
2020-01-17T08:42:36Z
dc.date.issuedpl
2014
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
2
dc.description.physicalpl
273-285
dc.description.pointspl
20
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
55
dc.identifier.doipl
10.1007/s13353-014-0198-9
dc.identifier.eissnpl
2190-3883
dc.identifier.issnpl
1234-1983
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/133324
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa
dc.rights.licence
CC-BY
dc.rights.uri*
https://creativecommons.org/licenses
dc.share.type
inne
dc.source.integrator
false
dc.subject.enpl
antimutagen
dc.subject.enpl
antimutagenicity
dc.subject.enpl
DNA damage
dc.subject.enpl
mutagen
dc.subject.enpl
mutagenicity
dc.subtypepl
ReviewArticle
dc.titlepl
Antimutagenic compounds and their possible mechanisms of action
dc.title.journalpl
Journal of Applied Genetics
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
15
Views per month
Views per city
Ashburn
4
Des Moines
3
Wroclaw
2
Dublin
1
Ruda Śląska
1
Wellington
1
Downloads
sloczynka_et-al_possible_mechanisms_of_action_2014.pdf
56
sloczynka_et-al_possible_mechanisms_of_action_2014.odt
22